Enveric Biosciences, Inc. (ENVB) vs GT Biopharma, Inc. (GTBP)

A side-by-side comparison of Enveric Biosciences, Inc. and GT Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Enveric Biosciences, Inc. logo
ENVB
Enveric Biosciences, Inc.
$7M
$1.47HealthcareDelayed quote: Oct 6, 2026, 2:52 PM EDT
GT Biopharma, Inc. logo
GTBP
GT Biopharma, Inc.
$8M
$6.42HealthcareDelayed quote: Oct 6, 2026, 2:57 PM EDT

Total return — ENVB vs GTBP

growth of $100 · dividends reinvested · last 10y
ENVB -100.0% (-75.0%/yr)GTBP -100.0% (-70.6%/yr)GTBP compounded faster over this window
Log scale — wide-divergence pair
000001101001kStart $10020182020202220242026$0$0
ENVB GTBP

ENVB vs GTBP: by the numbers

  • •GTBP is the larger company ($8M vs $7M market cap).

Metrics side by side

Valuation

MetricENVBGTBP
P/B ratio0.812.27

Profitability

MetricENVBGTBP
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-108.00%-618.74%
ROIC-107.99%-457.75%

Growth (annualized)

MetricENVBGTBP
Total return CAGR (5Y)N/A-73.13%

Go deeper

Full ENVB analysisFull GTBP analysisInteractive comparison tool

Dig into the metrics

Enveric Biosciences ROEGT Biopharma ROEEnveric Biosciences operating marginGT Biopharma operating marginEnveric Biosciences revenue growthGT Biopharma revenue growthEnveric Biosciences free cash flowGT Biopharma free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.